PTC Therapeutics Inc.

NASDAQ: PTCT · Real-Time Price · USD
47.25
-0.61 (-1.27%)
At close: May 28, 2025, 3:59 PM
47.01
-0.51%
After-hours: May 28, 2025, 07:42 PM EDT
-1.27%
Bid 43.1
Market Cap 3.74B
Revenue (ttm) 1.77B
Net Income (ttm) 594.84M
EPS (ttm) 6.51
PE Ratio (ttm) 7.26
Forward PE -17.14
Analyst Buy
Ask 50
Volume 514,862
Avg. Volume (20D) 1,237,238
Open 47.89
Previous Close 47.86
Day's Range 47.15 - 48.19
52-Week Range 28.72 - 58.38
Beta 0.52

About PTCT

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PTCT
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PTCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
+12.63%
PTC Therapeutics shares are trading higher after t... Unlock content with Pro Subscription
3 weeks ago
-18.62%
PTC Therapeutics shares are trading lower. The company announced results from the Phase 2 PIVOT-HD study of PTC518 in Stage 2 and Stage 3 Huntington's disease patients.